Publications by authors named "Thomas Badgett"

9Publications

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.

Cancer Discov 2014 Feb 23;4(2):216-31. Epub 2014 Jan 23.

1Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, NIH; 2Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland; 3Broad Institute of MIT and Harvard, Cambridge; 4Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Department of Pathology, Harvard Medical School, Boston, Massachusetts; 6University of Nebraska Medical Center, Omaha, Nebraska; 7Department of Pediatrics, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas; and 8Department of Pediatrics, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; 9The Tumour Bank, The Children's Cancer Research Unit, The Children's Hospital at Westmead, Westmead, New South Wales, Australia; 10Department of Oncology, Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462130PMC
February 2014

Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.

BMC Cancer 2012 Mar 21;12:101. Epub 2012 Mar 21.

Oncogenomics Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/1471-240
Publisher Site
http://dx.doi.org/10.1186/1471-2407-12-101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364855PMC
March 2012

Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.

Cancer Biol Ther 2009 Dec 27;8(24):2386-95. Epub 2009 Dec 27.

Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Gaithersburg, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829338PMC
http://dx.doi.org/10.4161/cbt.8.24.10184DOI Listing
December 2009

New Technologies for Diagnosing Pediatric Tumors Expert Opinion on Medical Diagnostics.

Expert Opin Med Diagn 2008 Nov;2(11):1205-1219

Oncogenomic Section, Pediatric Oncology Branch, Advanced Technology Center, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 8717 Grovemont Circle, Bethesda, Maryland 20892-4605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17530059.2.11.1205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700769PMC
November 2008

Preschool vision screening in primary care after a legislative mandate for diagnostic eye examinations.

South Med J 2003 Sep;96(9):859-62

Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, 6C19 300 N. Ingalls Building, Ann Arbor, MI 48109-0456, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.SMJ.0000054937.26303.95DOI Listing
September 2003